Sarah Scollon

Update on Cancer and Central Nervous System Tumor Surveillance in Pediatric <i>NF2</i> -, <i>SMARCB1</i> -, and <i>LZTR1</i> -Related Schwannomatosis

Update on Pediatric Surveillance Recommendations for <i>PTEN</i> Hamartoma Tumor Syndrome, <i>DICER1-</i> Related Tumor Predisposition, and Tuberous Sclerosis Complex

Update on Pediatric Cancer Surveillance Recommendations for Patients with Neurofibromatosis Type 1, Noonan Syndrome, CBL Syndrome, Costello Syndrome, and Related RASopathies

Update on Recommendations for Surveillance for Children with Predisposition to Hematopoietic Malignancy

Update on Genetic Counselor Practice and Recommendations for Pediatric Cancer Predisposition Evaluation and Surveillance

Return of non-ACMG recommended incidental genetic findings to pediatric patients: considerations and opportunities from experiences in genomic sequencing

Phenotypic Differences in Juvenile Polyposis Syndrome With or Without a Disease-causing <i>SMAD4</i>/<i>BMPR1A</i> Variant

The Clinical Sequencing Evidence-Generating Research Consortium: Integrating Genomic Sequencing in Diverse and Medically Underserved Populations

Retinoblastoma and Neuroblastoma Predisposition and Surveillance

Cancer Screening Recommendations and Clinical Management of Inherited Gastrointestinal Cancer Syndromes in Childhood

Haploinsufficiency of the Chromatin Remodeler BPTF Causes Syndromic Developmental and Speech Delay, Postnatal Microcephaly, and Dysmorphic Features

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions

Diagnostic Yield of Clinical Tumor and Germline Whole-Exome Sequencing for Children With Solid Tumors

Clinical Sequencing Exploratory Research Consortium: Accelerating Evidence-Based Practice of Genomic Medicine

Experiences with obtaining informed consent for genomic sequencing

Parent decision‐making around the genetic testing of children for germline <i>TP53</i> mutations